Tim Wilsdon moderates the session discussing how to fast-track policy solutions that could address the barriers preventing patient access to NGS and identify the ones that should be prioritized.
For more information on this event, click here.
Gene therapy competitive dynamics: Winner takes all
With many gene therapies in development for an increasing number of indications, their curative promise presents a unique competitive dynamic as they enter the...